British Journal of Cancer publishes first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK.
British Journal of Cancer publishes NET Patient Foundation’s research into impact of neuroendocrine morphology on cancer outcome and stage at diagnosis NET Patient Foundation in collaboration with Public Health England have undertaken the first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK to identify areas of unmet need with an aim to inform service improvement.
Recent News
Catherine Bouvier Ellis steps down after 19 years leading Neuroendocrine Cancer UK
Neuroendocrine Cancer UK today announces that Catherine Bouvier Ellis, its Co-Founder and Chief Executive Officer, will be stepping down from her role on October 8, 2025, after two decades of transformative leadership and unwavering dedication to the neuroendocrine...
Hero Awards 2025 – Now Live!
Neuroendocrine Cancer UK Hero Awards 2025 – Launch today!
‘SCAN’ Survey 2025 – One voice matters, thousands create change. Help improve care for NET patients!
Neuroendocrine Cancer UK is pleased to announce the launch of the International Neuroendocrine Cancer Alliance (INCA) ‘Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Cancer Patients’ (SCAN) 2025.